Microbial Biosensors are innovative devices that utilize living microorganisms to detect and respond to specific substances in their environment. These biosensors leverage the unique capabilities of microorganisms, such as bacteria, yeast, or algae, to act as biological sensing elements. The microorganisms are genetically engineered to express proteins or enzymes that interact with target molecules, triggering a measurable response. Microbial biosensors find applications in environmental monitoring, medical diagnostics, and industrial processes. In environmental monitoring, microbial biosensors are employed to detect pollutants, toxins, or pathogens in air, water, and soil. Their ability to provide real-time, on-site monitoring makes them valuable tools for assessing environmental quality. In medical diagnostics, microbial biosensors offer rapid and sensitive detection of biomarkers associated with diseases. They can be designed to respond to specific proteins, nucleic acids, or metabolites, aiding in the early diagnosis and monitoring of various medical conditions. In industrial settings, microbial biosensors are utilized for process control, ensuring optimal conditions in bioreactors or detecting contaminants in food and beverages. Their versatility and adaptability make them valuable in optimizing production processes and ensuring product quality. Despite their potential, challenges such as stability, reproducibility, and ethical considerations surrounding genetic modification persist. Ongoing research in microbial biosensors focuses on improving their performance, expanding their range of applications, and addressing ethical and regulatory concerns. As technology advances, microbial biosensors continue to play a crucial role in enhancing our ability to monitor and respond to environmental and biological changes.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy